West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
211.89
+1.25 (0.59%)
Jun 4, 2025, 12:13 PM - Market open
WST Revenue
West Pharmaceutical Services had revenue of $698.00M in the quarter ending March 31, 2025, with 0.37% growth. This brings the company's revenue in the last twelve months to $2.90B, down -1.12% year-over-year. In the year 2024, West Pharmaceutical Services had annual revenue of $2.89B, down -1.92%.
Revenue (ttm)
$2.90B
Revenue Growth
-1.12%
P/S Ratio
5.29
Revenue / Employee
$273,189
Employees
10,600
Market Cap
15.22B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.89B | -56.60M | -1.92% |
Dec 31, 2023 | 2.95B | 62.90M | 2.18% |
Dec 31, 2022 | 2.89B | 55.30M | 1.95% |
Dec 31, 2021 | 2.83B | 684.70M | 31.89% |
Dec 31, 2020 | 2.15B | 307.00M | 16.69% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
WST News
- 1 day ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services - GlobeNewsWire
- 14 days ago - 69 May Aristocrats: Buy 1 Of 38 "Safer" Dividend Dogs - Seeking Alpha
- 27 days ago - West to Participate in Upcoming Investor Conferences - PRNewsWire
- 4 weeks ago - Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. (WST) - GlobeNewsWire
- 5 weeks ago - Best Dividend Aristocrats For May 2025 - Seeking Alpha
- 5 weeks ago - West Pharmaceutical Defies Doubters: EPS Jumps, Outlook Raised Despite Tariff Drag - Benzinga
- 5 weeks ago - West Pharmaceutical Services, Inc. (WST) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - West Pharma raises profit forecast as dollar weakens amid Trump's tariff policies - Reuters